Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Accounts Receivable, Allowance for Credit Loss, Current	$ 5,000,000	$ 5,000,000
Finite-Lived Intangible Assets, Accumulated Amortization	434,000,000	385,000,000
Loans and Leases Receivable, Allowance	26,000,000	26,000,000
Other Noncurrent Assets, Allowance	51,000,000	23,000,000
Non Recourse Debt Current	1,758,000,000	1,367,000,000
Non Recourse Debt Non Current	$ 17,846,000,000	$ 13,603,000,000
Preferred Stock, Shares Authorized	50,000,000
Preferred Stock, Shares Issued	1,043,050
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,200,000,000	1,200,000,000
Common stock, shares issued (in shares)	818,790,001	818,717,043
Common stock, shares outstanding (in shares)	668,743,464	666,793,625
Treasury stock, shares (in shares)	150,046,537	151,923,418
Preferred stock (without par value, 50,000,000 shares authorized; 1,043,050 issued and outstanding at December 31, 2022 and December 31, 2021)	$ 838,000,000	$ 838,000,000
Common stock ($0.01 par value, 1,200,000,000 shares authorized; 818,790,001 issued and 668,743,464 outstanding at December 31, 2022 and 818,717,043 issued and 666,793,625 outstanding at December 31, 2021)	8,000,000	8,000,000
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Loans and Leases Receivable, Allowance	26,000,000	26,000,000
Consolidated Variable Interest Entities [Member]
Non Recourse Debt Current	416,000,000	302,000,000
Non Recourse Debt Non Current	2,295,000,000	2,223,000,000
Accounts Receivable
Accounts Receivable, Allowance for Credit Loss, Current	$ 3,000,000	$ 9,000,000